Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernarda Zamora

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Frontiers in Health Services|March 17, 2023
The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimatesBernarda Zamora, Adrian Towse
Health Policy (Amsterdam, Netherlands)|July 27, 2020
Examining the variation across acute trusts in patient delayed dischargeRussell DeVolder, Victoria Serra-Sastre, Bernarda Zamora
Cost Effectiveness and Resource Allocation : C/E|March 2, 2021
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?Bernarda Zamora, Louis P Garrison, Aig Unuigbe, et al.
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment-Rationale and Empirical SupportLouis P Garrison, Bernarda Zamora, Meng Li, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2019
Distribution of the EQ-5D-5L Profiles and Values in Three Patient GroupsYan Feng, Nancy Devlin, Andrew Bateman, et al.
Journal of Health Economics|April 13, 2013
Does hospital ownership affect patient experience? An investigation into public-private sector differences in EnglandVirginie Pérotin, Bernarda Zamora, Rachel Reeves, et al.
Orphanet Journal of Rare Diseases|May 5, 2019
Comparing access to orphan medicinal products in EuropeBernarda Zamora, Francois Maignen, Phill O'Neill, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2023
The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United KingdomMikel Berdud, Niklas Wallin-Bernhardsson, Bernarda Zamora, et al.
Journal of Health Services Research & Policy|September 6, 2011
Provider diversity in the English NHS: a study of recent developments in four local health economiesPauline Allen, Simon Turner, Will Bartlett, et al.
Cost Effectiveness and Resource Allocation : C/E|December 16, 2023
Resource allocation in public sector programmes: does the value of a life differ between governmental departments?Patricia Cubi-Molla, David Mott, Nadine Henderson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontiers in Health Services|March 17, 2023
The cost-per-QALY threshold in England: Identifying structural uncertainty in the estimatesBernarda Zamora, Adrian Towse
Health Policy (Amsterdam, Netherlands)|July 27, 2020
Examining the variation across acute trusts in patient delayed dischargeRussell DeVolder, Victoria Serra-Sastre, Bernarda Zamora
Cost Effectiveness and Resource Allocation : C/E|March 2, 2021
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?Bernarda Zamora, Louis P Garrison, Aig Unuigbe, et al.
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment-Rationale and Empirical SupportLouis P Garrison, Bernarda Zamora, Meng Li, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 6, 2019
Distribution of the EQ-5D-5L Profiles and Values in Three Patient GroupsYan Feng, Nancy Devlin, Andrew Bateman, et al.
Journal of Health Economics|April 13, 2013
Does hospital ownership affect patient experience? An investigation into public-private sector differences in EnglandVirginie Pérotin, Bernarda Zamora, Rachel Reeves, et al.
Orphanet Journal of Rare Diseases|May 5, 2019
Comparing access to orphan medicinal products in EuropeBernarda Zamora, Francois Maignen, Phill O'Neill, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2023
The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United KingdomMikel Berdud, Niklas Wallin-Bernhardsson, Bernarda Zamora, et al.
Journal of Health Services Research & Policy|September 6, 2011
Provider diversity in the English NHS: a study of recent developments in four local health economiesPauline Allen, Simon Turner, Will Bartlett, et al.
Cost Effectiveness and Resource Allocation : C/E|December 16, 2023
Resource allocation in public sector programmes: does the value of a life differ between governmental departments?Patricia Cubi-Molla, David Mott, Nadine Henderson, et al.
Pageof 2